North America Home Healthcare Market Outlook, 2028

The North America Home healthcare market is anticipated to grow at more than 7% CAGR by 2023–28

Featured Companies

  • 1. Beckton Dickinson
  • 2. Sanofi S.A.
  • 3. Abbott Laboratories
  • 4. Glanbia plc
  • 5. Medtronic plc
  • 6. B. Braun Melsungen AG
  • More...

In North America Home health care services enable individuals of all ages to recuperate at home instead of being sent to the hospital or placed in a skilled nursing facility while they are recuperating from an illness, surgery, or accident. People with physical or mental impairments may get help from home health care so they can live independently and avoid institutionalization or long-term care. Patients with chronic illnesses may maintain their freedom in the comfort of their own homes by receiving help managing their ailments at home. Patients and healthcare providers alike have been showing a preference for home-based care due to the comfort and convenience it provides. Home healthcare allows patients to receive medical attention in the familiar surroundings of their homes, reducing the need for hospital visits. Home healthcare services are often more cost-effective than inpatient care. As healthcare systems look for ways to manage costs, home-based care becomes an attractive option for both providers and payers. As hospitals aim to reduce the length of inpatient stays, home healthcare becomes crucial in providing continued care and support for patients recovering from surgeries or managing chronic conditions. Chronic diseases, such as diabetes, cardiovascular conditions, and respiratory disorders, are prevalent in the aging population. Home healthcare services play a crucial role in managing these conditions through regular monitoring, medication management, and lifestyle support. Home healthcare services contribute to reducing hospital readmission rates by providing continuous care and monitoring, especially for patients with chronic conditions. This aligns with healthcare goals to improve patient outcomes and reduce healthcare costs. In rural areas where access to healthcare facilities may be limited, home healthcare becomes a crucial means of delivering medical services. It helps bridge the gap between urban and rural healthcare accessibility. According to the research report, "North America Home Healthcare Market Outlook, 2028," published by Bonafide Research, the North America Home healthcare market is anticipated to grow at more than 7% CAGR by 2023–28. The adoption of telehealth services and remote monitoring technologies was on the rise. Telehealth allows healthcare professionals to conduct virtual consultations, while remote monitoring enables the continuous tracking of patient vital signs and health parameters from a distance. The integration of wearable devices for health monitoring was gaining traction. Patients and caregivers were increasingly using wearable devices to track and manage health conditions, promoting a more proactive approach to healthcare. AI and data analytics were being increasingly utilized in home healthcare for predictive analytics, treatment optimization, and decision support. These technologies help healthcare providers make informed decisions and enhance patient care. The integration of smart home technologies into home healthcare was becoming more prevalent. This included the use of smart devices and sensors to create a safer and more supportive home environment, especially for seniors and individuals with chronic conditions. The proliferation of mobile health applications allowed patients to actively participate in their healthcare management. These apps facilitated medication adherence, health tracking, and communication with healthcare providers, promoting greater patient engagement. There was a shift toward more flexible payment models for home healthcare services. This included value-based care arrangements and alternative payment models that focused on the quality and outcomes of care rather than the volume of services provided.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample
Based on country the market is segmented into United States, Mexico and Canada. In the United States, the home healthcare sector was characterized by a robust market driven by factors such as an aging population, technological advancements, and a growing preference for patient-centric care. The aging demographic in the U.S., coupled with a rising incidence of chronic diseases, underscored the importance of home healthcare services in providing personalized and cost-effective care solutions. Telehealth and remote monitoring technologies gained prominence, especially during the COVID-19 pandemic, fostering a shift towards virtual consultations and remote patient monitoring. The U.S. market also witnessed collaborations between healthcare providers, technology companies, and insurers, aiming to create integrated and comprehensive home healthcare solutions. In Mexico, the home healthcare market exhibited unique characteristics shaped by demographic factors, healthcare infrastructure, and cultural considerations. The country faced the challenges of providing healthcare access across diverse geographical regions, making home healthcare a crucial component, especially in rural areas. The cultural preference for familial care and the concept of aging in place contributed to the growth of home healthcare services in Mexico. Similar to the U.S., technological innovations played a pivotal role, with an increasing focus on leveraging telehealth and mobile health applications to enhance patient care and engagement. The Mexican home healthcare market also witnessed efforts to address social determinants of health, recognizing the impact of factors such as housing and social support on overall well-being. Based on Product & Services the market is categorized into Therapeutic, Testing, Screening, and Monitoring (TSM), Mobility and Services. Therapeutic services are crucial for individuals with chronic illnesses, such as diabetes, cardiovascular diseases, respiratory disorders, and arthritis. The aging population in North America tends to have a higher incidence of chronic conditions, leading to an increased demand for therapeutic home healthcare services. Many patients require therapeutic care after hospitalization for acute conditions or surgery. Home healthcare services, including therapeutic interventions, provide a convenient and cost-effective way for patients to continue their recovery process in the comfort of their homes. Many patients prefer to receive care in the familiar and comfortable environment of their homes. Therapeutic services, such as physical therapy or infusion therapy, can be more easily administered in a home setting, promoting patient compliance and overall well-being. Home therapeutic services are often more cost-effective than inpatient care. This cost efficiency is appealing to healthcare providers, payers, and patients alike. It can lead to reduced healthcare expenses while maintaining or improving the quality of care. Therapeutic services related to wound care are essential for individuals with chronic wounds, surgical wounds, or conditions like diabetes that require specialized care. Home healthcare providers can administer wound care, monitor healing progress, and educate patients on self-care practices, contributing to faster recovery and preventing complications. In terms of Indication the market is segmented into Cardiovascular Disorders & Hypertension, Cancer, Diabetes, Respiratory Diseases, Movement Disorders, Pregnancy, Hearing Disorders, Wound Care and Other Indications. Diabetes is a widespread chronic condition in North America, with a significant portion of the population affected. The prevalence of diabetes, both type 1 and type 2, has been steadily increasing. As the number of individuals diagnosed with diabetes rises, there is a growing need for specialized home healthcare services to manage the condition. Diabetes management involves daily self-monitoring of blood glucose levels, medication adherence, and lifestyle modifications. Home healthcare services empower patients by providing education, support, and tools to manage their condition effectively. This emphasis on patient engagement contributes to improved outcomes and a higher quality of life. Diabetes management is not only about medication; it requires a holistic approach that includes dietary management, exercise, mental health support, and regular monitoring. Home healthcare providers can offer comprehensive care plans that address all aspects of diabetes management, promoting a holistic and patient-centered approach. Companies Covered in this report:

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Novo Nordisk A/S, Sanofi S.A., Medtronic plc, Terumo Corporation, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, B. Braun Melsungen AG, Baxter International Inc., Nipro Corporation, Fresenius Medical Care AG & Co. KGaA, Abbott Laboratories , Koninklijke Philips N.V. Considered in this report • Geography: North America • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval
Aspects covered in this report • North America Home Healthcare market Outlook with its value and forecast along with its segments • Country-wise Home Healthcare market analysis • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation Country covered in the report: • United States • Canada • Mexico By Product & Services • Therapeutic • Testing, Screening, and Monitoring (TSM) • Mobility • Services By Indication • Cardiovascular Disorders & Hypertension • Cancer • Diabetes • Respiratory Diseases • Movement Disorders • Pregnancy • Hearing Disorders • Wound Care • Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV) The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Home Healthcare industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.

Companies Mentioned

  • Beckton Dickinson
  • Sanofi S.A.
  • Abbott Laboratories
  • Glanbia plc
  • Medtronic plc
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • Huntsman International LLC
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche AG,
  • Fresenius Medical Care AG & Co. KGaA

Table of Contents

  • Table of Contents
  • 1. Executive Summary
  • 2. Research Methodology
  • 2.1. Secondary Research
  • 2.2. Primary Data Collection
  • 2.3. Market Formation & Validation
  • 2.4. Report Writing, Quality Check & Delivery
  • 3. Market Structure
  • 3.1. Market Considerate
  • 3.2. Assumptions
  • 3.3. Limitations
  • 3.4. Abbreviations
  • 3.5. Sources
  • 3.6. Definitions
  • 4. Economic /Demographic Snapshot
  • 5. Global Home Healthcare Market Outlook
  • 5.1. Market Size By Value
  • 5.2. Market Share By Region
  • 5.3. Market Size and Forecast, By Product and Services
  • 5.4. Market Size and Forecast, By Indication
  • 6. North America Home Healthcare Market Outlook
  • 6.1. Market Size By Value
  • 6.2. Market Share By Country
  • 6.3. Market Size and Forecast, By Product and Services
  • 6.4. Market Size and Forecast, By Indication
  • 7. Market Dynamics
  • 7.1. Market Drivers & Opportunities
  • 7.2. Market Restraints & Challenges
  • 7.3. Market Trends
  • 7.4. Covid-19 Effect
  • 7.5. Supply chain Analysis
  • 7.6. Policy & Regulatory Framework
  • 7.7. Industry Experts Views
  • 7.8. United States Home Healthcare Market Outlook
  • 7.8.1. Market Size By Value
  • 7.8.2. Market Size and Forecast By Product and Services
  • 7.8.3. Market Size and Forecast By Indication
  • 7.9. Canada Home Healthcare Market Outlook
  • 7.9.1. Market Size By Value
  • 7.9.2. Market Size and Forecast By Product and Services
  • 7.9.3. Market Size and Forecast By Indication
  • 7.10. Mexico Home Healthcare Market Outlook
  • 7.10.1. Market Size By Value
  • 7.10.2. Market Size and Forecast By Product and Services
  • 7.10.3. Market Size and Forecast By Indication
  • 8. Competitive Landscape
  • 8.1. Competitive Dashboard
  • 8.2. Business Strategies Adopted by Key Players
  • 8.3. Key Players Market Positioning Matrix
  • 8.4. Porter's Five Forces
  • 8.5. Company Profile
  • 8.5.1. Novo Nordisk A/S
  • 8.5.1.1. Company Snapshot
  • 8.5.1.2. Company Overview
  • 8.5.1.3. Financial Highlights
  • 8.5.1.4. Geographic Insights
  • 8.5.1.5. Business Segment & Performance
  • 8.5.1.6. Product Portfolio
  • 8.5.1.7. Key Executives
  • 8.5.1.8. Strategic Moves & Developments
  • 8.5.2. Sanofi S.A.
  • 8.5.3. Medtronic plc
  • 8.5.4. Terumo Corporation
  • 8.5.5. Becton, Dickinson and Company
  • 8.5.6. F. Hoffmann-La Roche AG
  • 8.5.7. B. Braun Melsungen AG
  • 8.5.8. Baxter International Inc.
  • 8.5.9. Nipro Corporation
  • 8.5.10. Fresenius Medical Care AG & Co. KGaA
  • 8.5.11. Abbott Laboratories
  • 8.5.12. Koninklijke Philips N.V.
  • 9. Strategic Recommendations
  • 10. Annexure
  • 10.1. FAQ`s
  • 10.2. Notes
  • 10.3. Related Reports
  • 11. Disclaimer

List of Table
Table 1 : Global Home Healthcare Market Snapshot, By Segmentation (2022 & 2028) (in USD Billion)
Table 2: Top 10 Counties Economic Snapshot 2020
Table 3: Economic Snapshot of Other Prominent Countries 2020
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5 : Global Home Healthcare Market Size and Forecast, By Product and Services (2017 to 2028F) (In USD Billion)
Table 6 : Global Home Healthcare Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 7 : North America Home Healthcare Market Size and Forecast, By Product and Services (2017 to 2028F) (In USD Billion)
Table 8 : North America Home Healthcare Market Size and Forecast, By Indication (2017 to 2028F) (In USD Billion)
Table 9 : Influencing Factors for Home Healthcare Market, 2022
Table 10 : United States Home Healthcare Market Size and Forecast By Product and Services (2017 to 2028F) (In USD Billion)
Table 11 : United States Home Healthcare Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 12 : Canada Home Healthcare Market Size and Forecast By Product and Services (2017 to 2028F) (In USD Billion)
Table 13 : Canada Home Healthcare Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)
Table 14 : Mexico Home Healthcare Market Size and Forecast By Product and Services (2017 to 2028F) (In USD Billion)
Table 15 : Mexico Home Healthcare Market Size and Forecast By Indication (2017 to 2028F) (In USD Billion)

List of Figures
Figure 1: Global Home Healthcare Market Size (USD Billion) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Global Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 5: Global Home Healthcare Market Share By Region (2022)
Figure 6: North America Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 7: North America Home Healthcare Market Share By Country (2022)
Figure 8: US Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 9: Canada Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 10: Mexico Home Healthcare Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 11: Competitive Dashboard of top 5 players, 2022
Figure 12: Porter's Five Forces of Global Home Healthcare Market

Market Research FAQs

The North America Home Healthcare market is anticipated to grow at more than 7% CAGR by 2023–28.

The growth of the home healthcare market in North America is influenced by factors such as an aging population, the preference for home-based care, advancements in technology, and the increasing prevalence of chronic diseases.

The major contributors to the North America Home Healthcare Market include the United States and Canada. These countries have well-established healthcare infrastructures and aging populations, driving the demand for home healthcare services.

Advancements in technology, such as telehealth, remote patient monitoring, and wearable devices, are playing a crucial role in the home healthcare sector. These technologies enhance communication between healthcare providers and patients, improve monitoring, and contribute to more efficient care delivery.

Challenges include regulatory complexities, reimbursement issues, workforce shortages, and the need for interoperability among healthcare technologies. Addressing these challenges is crucial for sustained growth in the home healthcare sector.
Logo

North America Home Healthcare Market Outlook, 2028

Contact usWe are friendly and approachable, give us a call.